BioProject,Run,EV_type,Source,disease,Disease_stage/treatment,Release_date,URL,EV isolated method,Project_Title,Project_Description
PRJNA675360,SRR13005805,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
PRJNA675360,SRR13005806,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
PRJNA675360,SRR13005807,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
PRJNA675360,SRR13005808,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
PRJNA675360,SRR13005809,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
PRJNA675360,SRR13005810,sEV,Cell line|Cell line/HCT116|Colorectum,Colorectal cancer,-,2023-11-08,https://pubmed.ncbi.nlm.nih.gov/34371001/,-,The Enterotoxigenic Bacteroides fragilis (ETBF) in intestinal inflammation and colorectal carcinogenesis [exosomes] (human),"To elucidate whether  Enterotoxigenic Bacteroides fragilis (ETBF) plays a role in  intestinal inflammation and colorectal carcinogenesis, a RNA-seq analysis was performed to compare the microRNA profiles of  exosomes derived from ETBF-treated HCT116 colorectal cancer cell lines.
Overall design: miRNA-seq was performed in exosomes derived from HCT116 colorectal cancer cells after ETBF treatment."
